Cancer News and Research

Latest Cancer News and Research

Researchers identify risk factors for healthy survival in men

Avoiding health risk factors in midlife such as smoking, being overweight, excessive drinking and hypertension is associated with a longer and healthier life in men, according to a study in the November 15 issue of JAMA: The Journal of the American Medical Association, a theme issue on men's health.

14 Nov 2006

New gold standard of care for overactive bladder

A major clinical trial finds that a combination of two common medications -- tolterodine (Detrol LA) and tamsulosin (Flomax) -- works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).

14 Nov 2006

Novel drug boosts platelets in ITP

Attacking a platelet-depleting autoimmune disease in a whole new way, an experimental drug is helping patients with immune thrombocytopenic purpura (ITP) once again produce healthy amounts of platelets -- with no major side effects.

14 Nov 2006

Approval for face transplants from Royal College along with stern warning

Britain's Royal College of Surgeons has given their approval, albeit with some reservations, for face transplants to go ahead.

14 Nov 2006

Link between common lifestyle factors, immune system and cancer

The immune system is fickle, and easily influenced by more than just viruses and bacteria. It can be swayed by the seemingly unexpected, such as by what we eat, for example, and affected by surprising sources.

13 Nov 2006

Optical amplification of photothermal therapy with gold nanoparticles and nanoclusters

Gold nanoparticles, through their unique ability to convert light into heat, show great promise as miniature heaters capable of cooking cancer cells to death.

13 Nov 2006

Modified silicon-based surfaces provide good home to proteins

Silicon, whether in its elemental form as silicon wafers or in its oxidized form, known as silicon dioxide or silica, is proving to be a valuable material for biomedical nanotechnology, in large part because of the biocompatibility and chemical inertness of these substances.

13 Nov 2006

Polymer coating improves tumor-targeting nanoparticles

Adding a thin coating of the biocompatible polymer poly(ethylene glycol) (PEG) to the surface of sulfur-modified, or thiolated, nanoparticles designed to fall apart inside tumors, prolongs the time that the resulting nanoparticles remain in tumors.

13 Nov 2006

A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas

In a dramatic demonstration of the power of nanotechnology, a team of investigators has designed a nanoscale, polymeric drug delivery vehicle that when loaded with a widely used anticancer agent cures colon cancer in mice with a single dose.

13 Nov 2006

Scientists shed light on the roll of junk DNA

University of Iowa scientists have made a discovery that broadens understanding of a rapidly developing area of biology known as functional genomics and sheds more light on the mysterious, so-called "junk DNA" that makes up the majority of the human genome.

13 Nov 2006

LaVeist named inaugural William C. and Nancy F. Richardson Professor in health policy

The Johns Hopkins Bloomberg School of Public Health has named Thomas A. LaVeist, PhD, the inaugural William C. and Nancy F. Richardson Professor in Health Policy. LaVeist, a leader in the study of minority health and the elimination of health disparities, was officially installed during a ceremony at the Bloomberg School of Public Health on November 10.

13 Nov 2006

New cancer treatments use body's own immune system to kill melanoma tumours

Scientists are claiming that the body's own immune system could be used to fight the most serious form of skin cancer, malignant melanoma.

13 Nov 2006

Sugar and fizzy drinks linked to pancreatic cancer

Swedish research has linked the risk of developing cancer of the pancreas to the consumption of sugar and fizzy drinks.

13 Nov 2006

SpectraScience files new patent application

SpectraScience has announced that it has filed for a new patent with the United States Patent and Trademark Office.

13 Nov 2006

Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer

Almost half of newly diagnosed breast cancer patients are found to have clinically significant emotional distress or symptoms of psychiatric disorders before treatment is begun, according to a new study published in the December 15, 2006 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

13 Nov 2006

Muscle protein myosin VI involved in the development of prostate cancer

Researchers at the Johns Hopkins Kimmel Cancer Center have for the first time implicated the muscle protein myosin VI in the development of prostate cancer and its spread.

8 Nov 2006

Inhibiting a particular cancer-causing gene improves radiation effectiveness

Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia has found.

8 Nov 2006

Kaposi's sarcoma-associated herpesvirus tricks cells to become tumors

Researchers at the University of Pennsylvania School of Medicine have discovered how the Kaposi's sarcoma-associated herpesvirus (KSHV) subverts a normal cell process in order to promote tumor growth.

8 Nov 2006

Cost-effectiveness of lipid screening in Hodgkin's disease survivors

Hodgkin's lymphoma survivors who have lipid screening every five years to detect high cholesterol will live a half year longer than patients who don't have the screening and the intervention is cost-effective, according to a study presented November 8, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.

8 Nov 2006

Bionomics delivers on milestones for cancer, anxiety and multiple sclerosis programs

Australian drug discovery company Bionomics Limited today updated shareholders at its Annual General Meeting on the recent progress of its anti-cancer drug BNC105 and drug discovery programs in anxiety and Multiple Sclerosis.

8 Nov 2006

Cancer News and Research

Latest Cancer News and Research

Researchers identify risk factors for healthy survival in men

New gold standard of care for overactive bladder

Novel drug boosts platelets in ITP

Approval for face transplants from Royal College along with stern warning

Link between common lifestyle factors, immune system and cancer

Optical amplification of photothermal therapy with gold nanoparticles and nanoclusters

Modified silicon-based surfaces provide good home to proteins

Polymer coating improves tumor-targeting nanoparticles

A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas

Scientists shed light on the roll of junk DNA

LaVeist named inaugural William C. and Nancy F. Richardson Professor in health policy

New cancer treatments use body's own immune system to kill melanoma tumours

Sugar and fizzy drinks linked to pancreatic cancer

SpectraScience files new patent application

Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer

Muscle protein myosin VI involved in the development of prostate cancer

Inhibiting a particular cancer-causing gene improves radiation effectiveness

Kaposi's sarcoma-associated herpesvirus tricks cells to become tumors

Cost-effectiveness of lipid screening in Hodgkin's disease survivors

Bionomics delivers on milestones for cancer, anxiety and multiple sclerosis programs

Industry Focus eBook - Oncology (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in